I read the recent article "Prophylactic Radiofrequency Ablation in Asymptomatic Patients With Wolff-Parkinson-White Is Not Yet a Good Strategy: A Decision Analysis" by Chevalier et al 1 with interest. I found their table confusing and possibly erroneous. Although their abbreviation MS is not spelled out, the proportion of 0.001 reported for MS/Wolff-Parkinson-White seems to be the event probability for intermittent Wolff-Parkinson-White patients (not asymptomatic patients) as reported by Montoya et al. 2 Although the reported radiofrequency ablation (RF) success event rate is the accepted acute success rate by ablation centers, their reference 3 does not address RF success. More importantly, the next 11 event rates reported refer to a reference on Markov modeling that does not address Wolff−Parkinson−White or RF ablation. 4 Many of these reported rates, as well as those provided by experts and used in their flow diagram, have no bearing on reality. For example, complete atrioventricular block and tamponade do not occur in proportions of 0.28 or 0.32 of cases. Their Figure I in the online-only Data Supplement confirms that these inappropriate proportions were entered in their decision model. I question whether they have misinterpreted percentages in the literature as proportions, resulting in 100-fold overestimation of complication rates. In any event, their decision analysis using these event rates is clearly flawed.
Finally, it should be stressed that even if corrected, their findings were based on a target population of 20-to 40-year-olds and thus have little bearing on the recently published "PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern" aimed at 8-to 21-year-old patients. 5
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